ERBB2 and neoplasm: In most HER2-positive tumors, elevated HER2 regulates PI3K-Akt signaling to activate the nuclear translocation of the NFκB-p65/p50 complex, resulting in the release of inflammatory cytokines and growth factors that inhibit apoptosis and promote tumor proliferation, angiogenesis, and tumor invasion35,43–45.